Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
41.80 GBX | +9,996.62% | -1.42% | +3.21% |
09-02 | Alliance Pharma plc Announces Termination of Jeyan Heper as Director | CI |
08-12 | EXECUTIVE CHANGES: New chief executives at Cornish Metals and ValiRx | AN |
Company Valuation: Alliance Pharma plc
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 444.1 | 466.6 | 585.4 | 286.2 | 218.9 | 223.8 | - | - |
Change | - | 5.06% | 25.47% | -51.11% | -23.53% | 2.26% | - | - |
Enterprise Value (EV) 1 | 503.3 | 576 | 672.4 | 388.2 | 310.1 | 298 | 274.3 | 243.4 |
Change | - | 14.44% | 16.74% | -42.26% | -20.13% | -3.89% | -7.95% | -11.25% |
P/E ratio | 17.8x | 57.6x | 80.6x | 312x | -6.61x | 14.3x | 11.1x | 9.79x |
PBR | 1.62x | 1.66x | 2.07x | 0.99x | - | 0.98x | 0.82x | 0.81x |
PEG | - | -0.8x | -7.2x | -3.6x | 0x | -0x | 0.4x | 0.7x |
Capitalization / Revenue | 3.27x | 3.59x | 3.45x | 1.66x | 1.2x | 1.18x | 1.11x | 1.06x |
EV / Revenue | 3.71x | 4.44x | 3.96x | 2.26x | 1.7x | 1.58x | 1.36x | 1.15x |
EV / EBITDA | 12.8x | 14.9x | 13.8x | 9.91x | 6.89x | 6.91x | 5.92x | 4.91x |
EV / EBIT | 13.4x | 15.6x | 14.7x | 10.9x | 7.41x | 7.42x | 6.33x | 5.23x |
EV / FCF | 17.3x | 16.9x | 20.3x | 24.6x | 10.1x | 11.4x | 9.22x | 7.78x |
FCF Yield | 5.78% | 5.92% | 4.93% | 4.07% | 9.91% | 8.76% | 10.8% | 12.9% |
Dividend per Share 2 | 0.00536 | 0.0161 | 0.0169 | 0.0178 | - | 0.00447 | 0.00476 | - |
Rate of return | 0.64% | 1.84% | 1.55% | 3.35% | - | 1.08% | 1.15% | - |
EPS 2 | 0.0472 | 0.0152 | 0.0135 | 0.0017 | -0.0613 | 0.0289 | 0.0373 | 0.0423 |
Distribution rate | 11.4% | 106% | 125% | 1,045% | - | 15.5% | 12.8% | - |
Net sales 1 | 135.6 | 129.8 | 169.6 | 172 | 182.7 | 189 | 202 | 211 |
EBITDA 1 | 39.4 | 38.6 | 48.57 | 39.19 | 44.99 | 43.1 | 46.37 | 49.61 |
EBIT 1 | 37.45 | 36.83 | 45.64 | 35.67 | 41.86 | 40.18 | 43.3 | 46.52 |
Net income 1 | 25.01 | 8.027 | 7.319 | 0.936 | -33.14 | 15.8 | 20.12 | 22.9 |
Net Debt 1 | 59.2 | 109.4 | 87 | 102 | 91.21 | 74.2 | 50.5 | 19.64 |
Reference price 2 | 0.8410 | 0.8760 | 1.0880 | 0.5300 | 0.4050 | 0.4140 | 0.4140 | 0.4140 |
Nbr of stocks (in thousands) | 528,077 | 532,606 | 538,045 | 539,995 | 540,390 | 540,566 | - | - |
Announcement Date | 07/04/20 | 23/03/21 | 22/03/22 | 21/03/23 | 19/06/24 | - | - | - |
P/E ratio, Detailed evolution
P/E ratio | EV / Sales | EV / EBITDA | Yield (Y) | Capi. ($) | ||
---|---|---|---|---|---|---|
14.34x | 1.58x | 6.91x | +1.08% | 296M | ||
39.08x | 7.95x | 28.89x | +0.75% | 52.65B | ||
18.44x | 1.69x | 8.41x | +1.55% | 30.01B | ||
26.78x | 2.02x | 10.29x | +1.52% | 17.67B | ||
28.4x | 4.55x | 18.08x | +0.61% | 15.94B | ||
23.99x | 4.7x | 16.17x | +0.55% | 12.99B | ||
11.79x | 2.04x | 8.13x | +4.14% | 6.39B | ||
32.38x | 3.12x | 16.67x | +0.19% | 5.55B | ||
Average | 24.40x | 3.46x | 14.19x | +1.30% | 17.69B | |
Weighted average by Cap. | 29.03x | 4.73x | 18.38x | +1.11% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- APH Stock
- Valuation Alliance Pharma plc
MarketScreener is also available in this country: United States.
Switch edition